Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024

Rhea-AI Summary

Corvus Pharmaceuticals, Inc. (CRVS) will host a conference call and webcast on March 19, 2024, to discuss business updates and report financial results for Q4 and full year 2023.

Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT

BURLINGAME, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on March 19, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update and report fourth quarter and full year 2023 financial results.

The conference call can be accessed by dialing 1-877-407-0784 (toll-free domestic) or 1-201-689-8560 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 90 days.

About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Corvus plans to initiate a Phase 3 registrational clinical trial for soquelitinib in patients with relapsed peripheral T cell lymphoma. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com.

INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
llea@corvuspharma.com

MEDIA CONTACT:
Sheryl Seapy
Real Chemistry
+1-949-903-4750
sseapy@realchemistry.com

When will Corvus Pharmaceuticals host a conference call and webcast?

Corvus Pharmaceuticals will host a conference call and webcast on March 19, 2024.

What is the ticker symbol for Corvus Pharmaceuticals?

The ticker symbol for Corvus Pharmaceuticals is CRVS.

What will be discussed during the conference call and webcast?

During the conference call and webcast, Corvus Pharmaceuticals will provide a business update and report fourth quarter and full year 2023 financial results.

How can one access the conference call?

The conference call can be accessed by dialing 1-877-407-0784 for toll-free domestic access or 1-201-689-8560 for international access. Alternatively, participants can click on the provided link for instant telephone access to the event.

Where can the live webcast be accessed?

The live webcast may be accessed via the investor relations section of the Corvus website.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available on Corvus’ website for 90 days.